日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer after prior vascular endothelial growth factor receptor-targeted therapy (COSMIC-311): outcomes by BRAF status

卡博替尼与安慰剂治疗既往接受过血管内皮生长因子受体靶向治疗的放射性碘难治性分化型甲状腺癌患者(COSMIC-311):按BRAF状态分析的疗效

Brose, Marcia S; Keam, Bhumsuk; Krajewska, Jolanta; Hoff, Ana O; Vaisman, Fernanda; Lin, Chia-Chi; Hitre, Erika; Bowles, Daniel W; Robinson, Bruce; Sherman, Steven I; Ngamphaiboon, Nuttapong; Guo, Xiang; Simmons, Andrew; Williamson, Denise; Andrianova, Svetlana; Berry, Nicholas; Capdevila, Jaume

Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial

体重指数与绝经后雌激素受体阳性乳腺癌患者延长芳香化酶抑制剂治疗的预后关系:SOLE试验的回顾性分析

Biganzoli, Giacomo; Isnaldi, Edoardo; Richard, François; Marano, Giuseppe; Boracchi, Patrizia; Maetens, Marion; Floris, Giuseppe; Neven, Patrick; Jerusalem, Guy; Munzone, Elisabetta; Hitre, Erika; Gombos, Andrea; Thompson, Alastair; Aebi, Stefan; Kammler, Roswitha; Dell'Orto, Patrizia; Viale, Giuseppe; Regan, Meredith M; Colleoni, Marco; Biganzoli, Elia; Desmedt, Christine

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

在放射性碘难治性分化型甲状腺癌患者中,无论既往是否接受过血管内皮生长因子受体靶向治疗以及肿瘤组织学类型如何,卡博替尼治疗均可延长无进展生存期:COSMIC-311 研究的亚组分析

Capdevila, Jaume; Krajewska, Jolanta; Hernando, Jorge; Robinson, Bruce; Sherman, Steven I; Jarzab, Barbara; Lin, Chia-Chi; Vaisman, Fernanda; Hoff, Ana O; Hitre, Erika; Bowles, Daniel W; Williamson, Denise; Levytskyy, Roman; Oliver, Jennifer; Keam, Bhumsuk; Brose, Marcia S

Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial

卡博替尼治疗既往接受过放射性碘难治性分化型甲状腺癌:COSMIC-311 III期试验的最新结果

Brose, Marcia S; Robinson, Bruce G; Sherman, Steven I; Jarzab, Barbara; Lin, Chia-Chi; Vaisman, Fernanda; Hoff, Ana O; Hitre, Erika; Bowles, Daniel W; Sen, Suvajit; Oliver, Jennifer W; Banerjee, Kamalika; Keam, Bhumsuk; Capdevila, Jaume

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

一线纳武利尤单抗联合化疗与单纯化疗治疗晚期胃癌、胃食管交界处癌和食管腺癌的疗效比较(CheckMate 649):一项随机、开放标签的3期临床试验

Janjigian, Yelena Y; Shitara, Kohei; Moehler, Markus; Garrido, Marcelo; Salman, Pamela; Shen, Lin; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Campos Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yanez, Patricio; Tehfe, Mustapha; Kowalyszyn, Ruben; Karamouzis, Michalis V; Bruges, Ricardo; Zander, Thomas; Pazo-Cid, Roberto; Hitre, Erika; Feeney, Kynan; Cleary, James M; Poulart, Valerie; Cullen, Dana; Lei, Ming; Xiao, Hong; Kondo, Kaoru; Li, Mingshun; Ajani, Jaffer A

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study

皮下注射曲妥珠单抗联合帕妥珠单抗和多西他赛治疗HER2阳性转移性乳腺癌:MetaPHER(一项IIIb期单臂安全性研究)的最终分析

Kuemmel, Sherko; Tondini, Carlo A; Abraham, Jacinta; Nowecki, Zbigniew; Itrych, Bartosz; Hitre, Erika; Karaszewska, Bogusława; Juárez-Ramiro, Alejandro; Morales-Vásquez, Flavia; Pérez-García, Jose Manuel; Cardona-Huerta, Servando; Monturus, Estefania; Sequi, Marco; Restuccia, Eleonora; Benyunes, Mark; Martín, Miguel

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

一项随机III期临床试验,评估聚乙二醇化透明质酸酶α联合白蛋白紫杉醇加吉西他滨治疗透明质酸高表达转移性胰腺腺癌患者的疗效

Van Cutsem, Eric; Tempero, Margaret A; Sigal, Darren; Oh, Do-Youn; Fazio, Nicola; Macarulla, Teresa; Hitre, Erika; Hammel, Pascal; Hendifar, Andrew E; Bates, Susan E; Li, Chung-Pin; Hingorani, Sunil R; de la Fouchardiere, Christelle; Kasi, Anup; Heinemann, Volker; Maraveyas, Anthony; Bahary, Nathan; Layos, Laura; Sahai, Vaibhav; Zheng, Lei; Lacy, Jill; Park, Joon Oh; Portales, Fabienne; Oberstein, Paul; Wu, Wilson; Chondros, Dimitrios; Bullock, Andrea J

Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer

代谢参数作为转移性结直肠癌患者无进展生存期和总生存期的预测因子

Nemeth, Zsuzsanna; Wijker, Wouter; Lengyel, Zsolt; Hitre, Erika; Borbely, Katalin

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230

预防早期绝经研究 (POEMS)/SWOG 跨组 S0230 的最终分析

Moore, Halle C F; Unger, Joseph M; Phillips, Kelly-Anne; Boyle, Frances; Hitre, Erika; Moseley, Anna; Porter, David J; Francis, Prudence A; Goldstein, Lori J; Gomez, Henry L; Vallejos, Carlos S; Partridge, Ann H; Dakhil, Shaker R; Garcia, Agustin A; Gralow, Julie R; Lombard, Janine M; Forbes, John F; Martino, Silvana; Barlow, William E; Fabian, Carol J; Minasian, Lori M; Meyskens, Frank L; Gelber, Richard D; Hortobagyi, Gabriel N; Albain, Kathy S

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy

戈舍瑞林用于乳腺癌辅助化疗期间的卵巢保护

Moore, Halle C F; Unger, Joseph M; Phillips, Kelly-Anne; Boyle, Frances; Hitre, Erika; Porter, David; Francis, Prudence A; Goldstein, Lori J; Gomez, Henry L; Vallejos, Carlos S; Partridge, Ann H; Dakhil, Shaker R; Garcia, Agustin A; Gralow, Julie; Lombard, Janine M; Forbes, John F; Martino, Silvana; Barlow, William E; Fabian, Carol J; Minasian, Lori; Meyskens, Frank L Jr; Gelber, Richard D; Hortobagyi, Gabriel N; Albain, Kathy S